Document is current
Any future updates will be listed below
-
Authors
Dash, Pujarini
Ghatak, Souvik
Topi, Geriolda
Satapathy, Shakti Ranjan
Ek, Fredrik
Hellman, Karin
Olsson, Roger https://orcid.org/0000-0002-7107-3472
Mehdawi, Lubna M.
Sjölander, Anita https://orcid.org/0000-0002-1495-4206
-
Funding
Funding for this research was provided by:
Kungliga Fysiografiska Sällskapet i Lund (2020-2021, 2020, 2020-2021)
Cancerfonden (18 0748)
Vetenskapsrådet (17-01274)
- License Information
-
More Information
Article History
Received: 17 October 2020
Revised: 30 September 2021
Accepted: 6 October 2021
First Online: 8 November 2021
Ethics approval and consent to participate
: Colorectal cancer patient follow-up started on the day of diagnosis and ended on the day of death, migration or December 31, 2000. Information on vital status and the cause of death was obtained from the Swedish Cause of Death Registry until December 31, 2000. The Ethical Committee at Lund University approved this study (LU 52-99 and 367/2005), which was performed in accordance with the Declaration of Helsinki. Informed consent was obtained from all subjects involved in the study. Transgenic zebrafish (<i>Danio rerio</i>), <i>Tg</i>(<i>fli1:EGFP</i>), were handled and used in accordance with the national legislation of Sweden and the European community guidelines for animal studies. All procedures were approved by the Ethical Committee at Malmö-Lund (permit no. M23-15, zebrafish larvae) [].
: The authors declare no competing interests.
